Health
FDA charts path for approval of individualized gene editing therapies
The FDA has outlined steps drugmakers can take to seek regulatory approval for gene editing medicines tailored to fix a single person's disease-causing mutation. The announcement is part of an ongoing ...
- Published
- (2 h ago)
- Outlet
- Endpoints News
- Section
- Health
- Length here
- Headline and 32-word snippet. The full article is at the source.
More from Endpoints News and around the same time
Why Zocdoc is clearing the way for AI personal agentsAmazon, Delta Air Lines and major US banks have blocked people from using personal AI agents to shop, book flights and manage transactions. But as agents start handling patients' healthcare tasks, at least one company ...Formation Bio unveils $600M fund tied to existing modelFormation Bio, an AI-focused biotech that acquires outside assets, develops them and then hands them off, has raised a $600 million investment found to double down on that strategy. The new fund will help it ...AstraZeneca’s bruising summer raises the stakes for 2027When one of AstraZeneca’s medicines, Wainua, failed a major late-stage heart disease trial in July, it was a jarring setback for a drugmaker whose research pipeline had become one of the most admired in the ...Citing 'safety' and 'freedom,' HHS will allow compounding of certain wellness peptidesHHS on Wednesday said it will stop enforcing a ban on the compounding of certain popular peptides used for wellness purposes while the FDA works on rulemaking to address the substances. The federal agency released ...Analysts press Biogen on lupus drug litifilimab ahead of pivotal readoutsScrutiny of Biogen’s late-stage pipeline is intensifying ahead of several Phase 3 readouts that are pivotal to CEO Chris Viehbacher's turnaround efforts. Analysts lobbed numerous questions at Viehbacher and other Biogen execs…Pfizer India site closure risks exacerbating cancer drug shortagesPfizer has been forced to temporarily close a cancer drug factory in India. The factory won’t reopen for up to two years and is already contributing to cancer drug shortages. In July, heavy monsoon rain ...This page holds the headline and a short snippet as published by Endpoints News, whose feed they came from. The story itself, the photography and the rights stay with them, and the button above goes straight to their site. We keep this page so the headline has a stable address and a record of when it ran.
